Lexicon Pharmaceuticals | Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
Abbott USD 11.6B 1.33B 2025-09
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 47.64M 579K 2025-09
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
AstraZeneca USD 6.55B 19.43B 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Coherus Biosciences USD 294.85M 2.33M 2025-03
Eli Lilly USD 40.87B 6.69B 2025-09
Esperion Therapeutics USD 262.48M 235.95M 2024-06
Halozyme Therapeutics USD 800.07M 709.03M 2025-09
Illumina USD 1.49B 496M 2025-12
Insmed USD 539.72M 21.23M 2025-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 39.41B 173M 2025-09
Lexicon Pharmaceuticals USD 56.11M 2.54M 2025-06
MacroGenics USD 70.26M 4K 2025-09
MannKind USD 303.65M 72.94M 2025-09
Merck USD 39.97B 6B 2025-09
Moderna USD 26M 6M 2025-09
Novartis USD 24.24B 174M 2025-09
PTC Therapeutics USD 1.84B 298.68M 2025-09
Puma Biotechnology USD 10.87M 222K 2025-06
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
Thermo Fisher Scientific USD 35.85B 4B 2025-12
Ultragenyx Pharmaceutical USD 782.75M 11.3M 2025-06
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12


Lexicon Pharmaceuticals Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.